MDS, Inc.
2810 Matheson Boulevard East
Suite 500
Mississauga,
ON L4W 4X7
Canada - Map
Phone: 905-267-4222
Fax: 905-267-4277
Web Site: http://www.mdsintl.com
| MDS, Inc., a life sciences company, provides products and services for the development of drugs, and the diagnosis and treatment of diseases. It operates in three segments: MDS Pharma Services, MDS Nordion, and MDS Analytical Technologies. The MDS Pharma Services segment provides pharmaceutical research services, including pre-clinical development, and Phase IV clinical trials for generic pharmaceutical and biotechnology companies, as well as consumer product and drug delivery companies. The MDS Nordion segment offers medical isotopes for molecular imaging, technologies for the sterilization of medical and other products, and contract manufacturing services for the radio therapeutics industry. The MDS Analytical Technologies segment focuses on the research, design, manufacture, and marketing of life sciences tools, such as high-end mass spectrometers and high-performance bio-analytical measurement systems. The company serves pharmaceutical manufacturers, biotechnology companies, manufacturers of medical supplies and devices, and academic and government institutions, as well as food and environmental testing industries. It sells its products and services in the United States, Europe, Asia, Canada, and internationally. The company, formerly known as MDS Health Group Limited, was founded in 1969 and is headquartered in Mississauga, Canada. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Stephen P. DeFalco , 47
Chief Exec. Officer, Pres and Non-Independent Director |
N/A
| N/A | Mr. Douglas S. Prince ,
Chief Financial Officer and Exec. VP of Fin. |
N/A
| N/A | Mr. Steve West ,
Chief Operating Officer and Pres of MDS Nordion |
N/A
| N/A | Mr. Andy Boorn ,
Pres of MDS Analytical Technologies |
N/A
| N/A | Mr. Ken Horton ,
Exec. VP of Corp. Devel. and Gen. Counsel |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
